Results 261 to 270 of about 51,662 (290)
Some of the next articles are maybe not open access.
Seminars in Oncology Nursing, 1991
I N 1806, FRENCH dermatologist Baron Jean Louis Alibert’ identified the unique characteristics of the disease process known today as cutaneous T-cell lymphoma (CTCL). He called it “mycosis fungoides” (MF), not because it was a fungus, but because of the mushroom-like nature of the cutaneous lesions found in the advanced stages of the disease.
K, Gilyon, T M, Kuzel
openaire +4 more sources
I N 1806, FRENCH dermatologist Baron Jean Louis Alibert’ identified the unique characteristics of the disease process known today as cutaneous T-cell lymphoma (CTCL). He called it “mycosis fungoides” (MF), not because it was a fungus, but because of the mushroom-like nature of the cutaneous lesions found in the advanced stages of the disease.
K, Gilyon, T M, Kuzel
openaire +4 more sources
The Journal of Dermatology, 1980
AbstractCutaneous T cell lymphoma (CTCL) is a generic classification of clonally‐derived malignancies of phenotypic helper/inducer T cells with a propensity to infiltrate the skin, migrate into the epidermis, localize in T cell zones of lymphoid structures and spare the bone marrow.
openaire +3 more sources
AbstractCutaneous T cell lymphoma (CTCL) is a generic classification of clonally‐derived malignancies of phenotypic helper/inducer T cells with a propensity to infiltrate the skin, migrate into the epidermis, localize in T cell zones of lymphoid structures and spare the bone marrow.
openaire +3 more sources
Current Opinion in Oncology, 1993
Cutaneous T-cell lymphoma, which usually presents as mycosis fungoides or Sézary syndrome, remains a mostly incurable, yet highly treatable group of diseases. The myriad of active therapies continues to grow, and new insights into the mechanism of systemic and topical therapies are being elucidated.
E H, Kaplan, W T, Leslie
openaire +2 more sources
Cutaneous T-cell lymphoma, which usually presents as mycosis fungoides or Sézary syndrome, remains a mostly incurable, yet highly treatable group of diseases. The myriad of active therapies continues to grow, and new insights into the mechanism of systemic and topical therapies are being elucidated.
E H, Kaplan, W T, Leslie
openaire +2 more sources
Seminars in Oncology Nursing, 1998
To describe the current state of the knowledge regarding the pathology, clinical presentation, treatment strategies, and nursing management of patients with cutaneous T-cell lymphoma, specifically, mycosis fungoides and the Sezary syndrome.Book chapters, review articles, published research studies, proceedings from professional meetings.Although ...
openaire +2 more sources
To describe the current state of the knowledge regarding the pathology, clinical presentation, treatment strategies, and nursing management of patients with cutaneous T-cell lymphoma, specifically, mycosis fungoides and the Sezary syndrome.Book chapters, review articles, published research studies, proceedings from professional meetings.Although ...
openaire +2 more sources
Medical Clinics of North America, 1982
Cutaneous T cell lymphoma is a malignancy of helper T cells, which have a propensity to infiltrate the skin. The incidence of the disease appears to exceed that of Hodgkin's disease, making it the most common lymphoma of adults. Advances in our knowledge of the biology of the malignant T cells should facilitate new and more effective forms of treatment.
J A, Patterson, R L, Edelson
openaire +2 more sources
Cutaneous T cell lymphoma is a malignancy of helper T cells, which have a propensity to infiltrate the skin. The incidence of the disease appears to exceed that of Hodgkin's disease, making it the most common lymphoma of adults. Advances in our knowledge of the biology of the malignant T cells should facilitate new and more effective forms of treatment.
J A, Patterson, R L, Edelson
openaire +2 more sources
Necrobiotic cutaneous T-cell lymphoma
Journal of the American Academy of Dermatology, 1999We report 3 patients with granulomatous cutaneous T-cell lymphoma (CTCL) who showed necrobiosis histologically with palisading granulomas. Although granulomatous change may be present in up to 4% of cases of CTCL, necrobiosis is rare. Misdiagnosis may occur if epidermotropism is minimal or if atypical cells are masked by the granulomatous infiltrate. T-
A, Woollons +4 more
openaire +2 more sources
Hematology/Oncology Clinics of North America
Cutaneous T-cell lymphoma is a group of non-Hodgkin T-cell lymphomas that develop in and affect the skin but can potentially spread to other organs. There are many subtypes, the most common of which are mycosis fungoides, Sezary syndrome, lymphomatoid papulosis, and primary cutaneous anaplastic large cell lymphoma.
David M, Weiner, Alain H, Rook
openaire +2 more sources
Cutaneous T-cell lymphoma is a group of non-Hodgkin T-cell lymphomas that develop in and affect the skin but can potentially spread to other organs. There are many subtypes, the most common of which are mycosis fungoides, Sezary syndrome, lymphomatoid papulosis, and primary cutaneous anaplastic large cell lymphoma.
David M, Weiner, Alain H, Rook
openaire +2 more sources
Dyshidrotic cutaneous T-cell lymphoma
Journal of the American Academy of Dermatology, 1996In 1887 Kaposi 1 first reported vesiculobullous skin lesions in a patient with mycosis fungoides. Since then only few additional reports of this rare clinical variant have been published. 2-9 In most patients blisters occurred in areas of preexisting mycosis fungoides.
T, Jakob +5 more
openaire +2 more sources
Rare Cutaneous T-Cell Lymphomas
Hematology/Oncology Clinics of North America, 2019Rare lymphoma includes the entities that occur in less than 1% of cases of all lymphomas. Although the percentage is low, there are more than eight lymphomas classified as rare lymphomas. This article describes clinical presentation, diagnosis, prognosis, and management of the most common rare lymphomas, including primary cutaneous γδ T-cell lymphoma ...
Fabiana, Damasco, Oleg E, Akilov
openaire +2 more sources
Cutaneous T-cell lymphoma/leukemia
Current Treatment Options in Oncology, 2000Effective treatment for cutaneous T-cell lymphomas (CTCL) requires an accurate and specific diagnosis based on the clinical presentation combined with evaluation of the histopathology, immunophenotyping, and gene rearrangement studies. Careful clinical and pathologic evaluation in centers familiar with the diverse forms of CTCL is most valuable for ...
R S, Siegel, T M, Kuzel
openaire +2 more sources